Performance of hepatitis B assays on the Bayer ADVIA Centaur® immunoassay system

Clinical Laboratory

Volumn 50, Issue 1-2, 2004, Pages 63-73

  van Helden, Josef ^a   Denoyel, Gerard ^b   Karwowska, Sylwia ^c   Reamer, Randy ^c   Schmalz, John ^c   Wright, Ted ^c   Preisel Simmons, Barbara ^c  

^a Laboratory Dr Stein/Partners   (Germany)

^b LMM Laboratoire Marcel Merieux   (France)

^c BAYER CORPORATION   (United States)

Author keywords

ADVIA Centaur; Diagnostic sensitivity; Diagnostic specificity; Hepatitis B virus (HBV); Performance evaluation; Seroconversion panels

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; AUTOMATION; BLOOD DONOR; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS REACTION; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EUROPE; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL PATIENT; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAGNETIC SEPARATION; MAJOR CLINICAL STUDY; MARKETING; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TECHNOLOGY;

AUTOANALYSIS; BLOOD DONORS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; SEROLOGIC TESTS;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 1442329692     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
2. Froesner G. Viral hepatitis. In: Thomas L, editor. Clinical Laboratory Diagnostics. Frankfurt, Th-Books, 1998; 1260-1287.
3. EAS Jury. EASL international consensus conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus Statement. J Hepatology 2003; 39: 533-40.
4. Hendriks HA, Kortlandt W, Verweij WM. Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. Clin Chem 2000; 46: 105-11.
5. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal of the European Communities 1998; L331:1-37.
6. Commission Decision on common technical specifications for in vitro-diagnostic medical devices. Official Journal of the European Communities 2002; L131:17-30.
7. NCCLS Document EP5-A- Evaluation of precision performance of clinical chemistry devices; Approved guideline, second edition (1999).